Status:
COMPLETED
Impact of an Intensified Thromboprofylaxis Protocol in COVID-19
Lead Sponsor:
Jessa Hospital
Conditions:
COVID19
Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to investigate and compare the mortality, the incidence of DVT and the incidence of kidney and liver failure in patients admitted to the ICU before and after the implementatio...
Detailed Description
Background Patients admitted to the Intensive Care Unit (ICU) are known to be at risk for thrombo-embolic events. Virchow's triad describes the major risk factors in three categories: venous stasis, v...
Eligibility Criteria
Inclusion
- \- All adult COVID19+ patients admitted to the ICU from 13th of March until 20th of April 2020.
Exclusion
- \- Patients younger than 18 years old.
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04394000
Start Date
May 4 2020
End Date
May 15 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa hospital
Hasselt, Belgium, 3500